FOS and esophageal cancer: Present investigation provides evidence of a constitutively activated AP-1 in esophageal cancers and demonstrates involvement of JunB, JunD and cFos as major DNA binding partners whereas it clearly negates the role of canonical AP-1 partner, cJun.